MGMT and glioblastoma: Taken together, these data from tissue studies highlight metabolites implicated in molecular mechanisms driving GBM evolution, even in the presence of IDH mutation and MGMT promoter methylation, highlighting the strong involvement of lipid metabolism and polyamine, nucleotide, and amino acid-related pathways.